Women Are the ‘Power Buyers’ of Healthcare. Here’s How to Serve Them Better

Women are the “power buyers” of healthcare, controlling about 80% of the healthcare spend in the U.S., which is a nearly $4 trillion industry. Women’s health is now in the spotlight, and investors have been quick to put their cash into this growing market. Digital health startups focused on women’s health care pulled in $1.3 billion in funding across 26 deals by October 2021—nearly doubling all of 2020’s funding with four months still left to go, according to digital health venture fund Rock Health. “You have to have blinders on, quite frankly, if you’re not understanding that dynamic and where the trend line is going,” said healthcare investor Lynne Chou O’Keefe, founder and managing partner at Define Ventures, during a Fierce JPM Week panel discussion.

Ivy Fertility Acquires Leading Mountain West Fertility Clinics

Ivy Fertility, a nationally and internationally recognized innovator in the field of advanced reproductive technologies, in-vitro fertilization, and third-party reproduction that is backed by InTandem Capital Partners, a healthcare services focused private equity firm, announced today it has acquired Utah Fertility Center, Nevada Center for Reproductive Medicine and Nevada Fertility Center, market-leading fertility services providers in the Mountain West region. The acquisition further expands Ivy Fertility’s reach into Nevada, Utah, Idaho and the Sierra Nevada region of California.

Boston IVF Welcomes Delaware Institute for Reproductive Medicine to Growing Fertility Network

Boston IVF, a worldwide leader in reproductive healthcare, is pleased to announce a new partnership with Delaware Institute for Reproductive Medicine, one of the most experienced fertility treatment providers in Delaware and the Mid-Atlantic region. With the acquisition, Delaware Institute for Reproductive Medicine joins Boston IVF’s growing fertility network across the United States, which includes more than thirty centers throughout New England, New York, Idaho, Indiana, Ohio, and Utah. Founded in 1986 by Dr. Jeffrey B. Russell as the first comprehensive infertility practice in the state, Delaware Institute for Reproductive Medicine (DIRM) has assisted in over 6,500 babies born and is among the East Coast’s most decorated providers of assisted reproductive technologies (ART).

Ivy Fertility Acquires Pacific NW Fertility and IVF Specialists to Expand Footprint

Ivy Fertility, a nationally and internationally recognized innovator in the field of advanced reproductive technologies, in-vitro fertilization, and third-party reproduction that is backed by InTandem Capital Partners, a healthcare services focused private equity firm, announced Thursday it has acquired Pacific NW Fertility and IVF Specialists (“PNWF”), a leading fertility provider group in Seattle, WA. PNWF is a world-class reproductive center committed to advancing the science of reproduction with the sole purpose of building families with compassion and individualized care. The collective experience of the physicians, embryologists, and the entire team at PNWF has solidified its position as a visionary in the field.

US Fertility Welcomes Center of Reproductive Medicine (CORM)

US Fertility, the largest physician-led partnership of top-tier fertility practices in the U.S., with more than 60 locations throughout CA, CO, IL, FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, and the Center of Reproductive Medicine (CORM), a nationally recognized fertility center serving Houston, the Texas Medical Center, Memorial City, Clear Lake, Beaumont, and surrounding areas in Texas — announced Tuesday that CORM will join the US Fertility partnership. SGF, the largest fertility practice partnership in the nation, was founded in 1991 and has 100,000 babies born to its credit. Following this transaction, SGF will have eight practices with 47 locations across the United States. CORM, the largest private fertility practice in the Greater Houston region, was founded in 1993 by Vicki Schnell, M.D.

LongueVue Capital Launches Fertility Specialists Network and Partners with IVFMD

LongueVue Capital (“LVC”), a New Orleans-based private equity firm, is pleased to announce that, in conjunction with fertility industry veterans H. Ron Davidson and Boris Vaisman, LVC has launched Fertility Specialists Network (“FSN”), a provider of clinical, operational, and administrative services to fertility practices, and has partnered with IVFMD, a leading fertility treatment platform with three locations serving the Dallas-Fort Worth metroplex (“DFW”). IVFMD will continue to operate locally through its existing brand and leverage the FSN network to support its physicians and employees, with a singular focus on providing superior outcomes for patients. Founded in 1997, IVFMD is one of the leading fertility centers in DFW.

New Study Estimates the Costs of U.S. Maternal Morbidity

In 2019, the estimated costs associated with maternal morbidity for U.S. births from conception through the child’s firth birthday were $32.3 billion, a new study found. The United States is experiencing a maternal health crisis. In 2019, the United States lagged other developed countries in maternal mortality ratio, with 20 maternal deaths per 100,000 live births. The new study, which was published today by The Commonwealth Fund, examined the medical and nonmedical costs associated with nine maternal morbidities: amniotic fluid embolism, cardiac arrest, gestational diabetes mellitus, hemorrhage, hypertensive disorders, maternal mental health conditions, renal disease, sepsis, and venous thromboembolism.

Forum Health Welcomes Tara Scott, MD and First Location in Ohio

Forum Health, LLC, the first nationwide network of integrative and functional medicine providers, has acquired Revitalize Medical Group, a functional medicine practice founded by Tara Scott, MD located in Fairlawn, Ohio. Revitalize Medical Group focuses on women’s health, treating hormonal imbalances, stress, thyroid issues, infertility, nutrition and more. Dr. Scott began as an OB/GYN and is nationally recognized for her work in hormone and wellness-related issues. She incorporates integrative medicine and evidence-based therapies to treat women’s hormone-related and chronic health concerns.

Everly Health Buys Startup Natalist to Expand Its Reach into Women’s Health, Retail Products

Everly Health is acquiring women’s health company Natalist, its third acquisition in six months. The companies did not disclose the financial details of the all-cash deal. Natalist offers women’s health, conception and pregnancy products, such as prenatal supplements and pregnancy and ovulation tests. With the acquisition, Everly Health, the parent company of health-testing kit brand Everlywell, is pushing deeper into women’s health and retail products. In addition to its signature pregnancy and ovulation tests, Natalist’s product suite supports women from pre-conception through pregnancy and includes tests, supplements, education and self-care items.

WELL Health Completes Majority Stake Acquisition of WISP, a Rapidly Growing Digital Health Leader Specializing in Women’s Health

WELL Health Technologies Corp. (TSX: WELL) (“WELL” or the “Company”), a company focused on empowering healthcare practitioners and their patients with best in class tech enabled healthcare services, is pleased to announce that it has completed the previously announced acquisition of a majority interest in WISP, a US technology leader and innovator in the delivery of quality virtual care and e-pharmacy experiences specializing in women’s health, for a total transaction value of approximately US$41.3 million, which includes a future conditional earn-out of up to approximately US$7.4 million (the “Transaction”).